A family history of premature CAD (P = 0.010), myocardial infarction (P < 0.001), and pharmacological history of β-blockers (P = 0.035), angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (P = 0.003), lipid-lowering drugs (P = 0.027), and diuretics usage (P = 0.007) were more prevalent in patients with TAK and coronary involvement. Here, ACE is linked to coronary artery disorder.